As COVID-19 cases continue to surge both in the U.S. and around the world, there’s promising news on the vaccine front. Pharmaceutical companies Pfizer, Moderna and, more recently, AstraZeneca have all announced that their vaccines have shown better-than-expected results.
Dr. Peter Hotez, the co-director of the Center for Vaccine Development at Texas Children’s Hospital, says that a vaccine release could begin for selected populations by the middle of December — and that a broader vaccination effort could soon follow.
“By the early part of next year, we’re going to move pretty quickly, I think, in vaccinating a significant percentage of the [U.S.] population,” Hotez says.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
